Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China flag China · Delayed Price · Currency is CNY
29.40
+0.13 (0.44%)
Sep 1, 2026, 4:00 PM EDT

SHE:301166 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-21.36-22.9510.1540.32106.6108.73
Depreciation & Amortization
22.9823.4422.4118.8811.676.65
Other Amortization
4.295.353.462.771.080.64
Loss (Gain) From Sale of Assets
-0.260.380.910-0.030.24
Asset Writedown & Restructuring Costs
4.09-000.020
Loss (Gain) From Sale of Investments
-19.1-20.72-29.45-30.03-22.61-
Provision & Write-off of Bad Debts
10.0510.056.143.7311.213
Other Operating Activities
2.735.283.5215.746.260.17
Change in Accounts Receivable
-116.270.6724.79-11.31-159.35-56.97
Change in Inventory
-14.12-1.6471.49-43.59-93.06-33.02
Change in Accounts Payable
9966.8-18.149.494.1532.97
Change in Other Net Operating Assets
-1.17-1.170.12-3.383.38-
Operating Cash Flow
-48.5852.4375.97-22.69-143.359.02
Operating Cash Flow Growth
--30.98%----36.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-84.86-96.05-71.2-63.18-61.5-14.31
Sale of Property, Plant & Equipment
0.080.090.020.110.110.11
Investment in Securities
183.18-256.82471.5-113.47-977.5-
Other Investing Activities
17.1418.4531.3926.820.61-
Investing Cash Flow
115.54-334.33431.71-149.74-1,018-14.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
----80-
Long-Term Debt Issued
-44.470.01---
Total Debt Issued
99.4744.470.01-80-
Short-Term Debt Repaid
------10
Long-Term Debt Repaid
--7.69-8.92-88.9-5.42-2.18
Total Debt Repaid
-52.16-7.69-8.92-88.9-5.42-12.18
Net Debt Issued (Repaid)
47.3136.78-8.91-88.974.58-12.18
Issuance of Common Stock
-----1,617
Repurchase of Common Stock
-18.26-18.26-19.5---
Common Dividends Paid
-52.46-19.98-40.72-78.84-44.26-20.2
Dividends Paid
-52.46-19.98-40.72-78.84-44.26-20.2
Other Financing Activities
1.38----11.15-6.8
Financing Cash Flow
-22.02-1.46-69.12-167.7419.171,578

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-4.48-2.950.710.61.69-0.41
Net Cash Flow
40.45-286.31439.26-339.57-1,1411,622

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-133.45-43.624.77-85.87-204.844.72
Free Cash Flow Growth
------48.77%
Free Cash Flow Margin
-11.63%-4.03%0.43%-7.00%-17.14%4.03%
Free Cash Flow Per Share
-1.55-0.490.06-1.00-2.360.68
Levered Free Cash Flow
-131.75-75.13-13.2-11.95-238.0531.39
Unlevered Free Cash Flow
-131.18-74.56-12.55-10.67-237.2431.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
43.9631.4446.0643.5342.8270
Change in Working Capital
-52.0151.658.84-74.1-257.51-60.41